The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 16, 2017
Filed:
Feb. 24, 2015
Applicants:
Emma Michelle Campbell, Horsham, GB;
Sofia Parveen, Horsham, GB;
Joe Buechler, Carlsbad, CA (US);
Gunars Valkirs, Escondido, CA (US);
Inventors:
Emma Michelle Campbell, Horsham, GB;
Sofia Parveen, Horsham, GB;
Joe Buechler, Carlsbad, CA (US);
Gunars Valkirs, Escondido, CA (US);
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/64 (2006.01); C07K 16/24 (2006.01); C12P 21/02 (2006.01); A61K 38/01 (2006.01); C12N 15/81 (2006.01); A61K 38/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 38/012 (2013.01); C12N 15/81 (2013.01); C12P 21/02 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); Y10S 514/853 (2013.01);
Abstract
The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.